Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Learmonth, Yvonne C ^a   Motl, Robert W ^a   Sandroff, Brian M ^a   Pula, John H ^b,c   Cadavid, Diego ^d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c Illinois Neurological Institute   (United States)

^d BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELEROMETER; ADULT; AGED; ARTICLE; BRAIN REGION; CEREBELLUM; CLINICAL ASSESSMENT TOOL; COGNITION; DEMOGRAPHY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MOBILIZATION; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PATIENT DETERMINED DISEASE STEP; VALIDITY; WALKING; DISABILITY; EXERCISE TEST; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY;

ADULT; AGED; DISABILITY EVALUATION; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PATIENT OUTCOME ASSESSMENT; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84877663889     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-37     Document Type: Article

References (34)

1. Kurtzke JF. Rating Neurologic Impairment in Multiple Sclerosis an Expanded Disability Status Scale (EDSS). Neurology 1983, 33:1444-1444. 10.1212/WNL.33.11.1444, 6685237.
2. Goldman MD, Motl RW, Rudick RA. Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Ther Adv Neurol Disord 2010, 3(4):229-39. 10.1177/1756285610374117, 3002657, 21179614.
3. Hohol MJ, Orav EJ, Weiner HL. Disease Steps in multiple sclerosis: A simple approach to evaluate disease progression. Neurology 1995, 45:251-255. 10.1212/WNL.45.2.251, 7854521.
4. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: A longitudinal study comparing Disease Steps and EDSS to evaluate disease progression. Mult Scler 1999, 5:349-354.
5. Schwartz CE, Vollmer T, Lee H. Reliability and validity of two self-report measures of impairment and disability for MS. Neurology 1999, 52:63-70. 10.1212/WNL.52.1.63, 9921850.
6. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004, 10:589-595. 10.1191/1352458504ms1085oa, 15471378.
7. Marrie RA, Goldman M. Validity of performance scales for disability assessment in multiple sclerosis. Mult Scler 2007, 13:1176-1182. 10.1177/1352458507078388, 17623733.
8. Lo AC, Hadjimichael O, Vollmer TL. Treatment patterns of multiple sclerosis patients: A comparison of veterans and non-veterans using the NARCOMS registry. Mult Scler 2005, 11:33-40. 10.1191/1352458505ms1136oa, 15732264.
9. Kobelt G, Berg J, Atherly D, Hadjimichael O. Costs and quality of life in multiple sclerosis: A cross-sectional study in the United States. Neurology 2006, 66:1696-1702. 10.1212/01.wnl.0000218309.01322.5c, 16769943.
10. Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D. Does multiple sclerosis-associated disability differ between races?. Neurology 2006, 66:1235-1240. 10.1212/01.wnl.0000208505.81912.82, 16636241.
11. Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T. Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain 2007, 127:35-41. 10.1016/j.pain.2006.07.015, 16949751.
12. Hadjimichael O, Vollmer T, Oleen-Burkey M. Fatigue characteristics in multiple sclerosis: The North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes 2008, 6:100. 10.1186/1477-7525-6-100, 2596785, 19014588.
13. Julian LJ, Vella L, Vollmer T, Hadjimichael O, Mohr DC. Employment in multiple sclerosis: exiting and re-entering the work force. J Neurol 2008, 255:1354-1360. 10.1007/s00415-008-0910-y, 3057081, 18677639.
14. Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology 2009, 72:117-124. 10.1212/01.wnl.0000333252.78173.5f, 2677495, 18971448.
15. Marrie RA, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Vascular comorbidity in associated with more rapid disability progression in multiple sclerosis. Neurology 2010, 74:1041-1047. 10.1212/WNL.0b013e3181d6b125, 2848107, 20350978.
16. Motl RW, McAuley E, Snook EM, Gliottoni RC. Physical activity and quality of life in multiple sclerosis: Intermediary roles of disability, fatigue, mood, pain, self-efficacy, and social support. Health Psych Med 2009, 14:111-124.
17. Gulick EE, Goodman S. Physical activity among people with multiple sclerosis. Int J MS Care 2006, 8:121-129.
18. Motl RW, Dlugonski D, Suh Y, Weikert M, Fernhall B, Goldman M. Accelerometry and its association with objective markers of walking limitations in ambulatory adults with multiple sclerosis. Arch Phys Med Rehabil 2010, 91:1942-1947. 10.1016/j.apmr.2010.08.011, 3165019, 21112438.
19. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW. Diagnostic criteria for multiple sclerosis: 2005 revisions to the " McDonald Criteria" Ann Neurol 2005, 58:840-846. 10.1002/ana.20703, 16283615.
20. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite measure (MFSC): An integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999, 5:244-50.
21. Nilsagard Y, Lundholm C, Gunnarsson LG, Dcnison E. Clinical relevance using timed walk tests and 'timed up and go' testing in persons with multiple sclerosis. Physiother Res Int 2007, 12:105-114. 10.1002/pri.358, 17536648.
22. Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler 2008, 14:383-390. 10.1177/1352458507082607, 17942508.
23. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: The 12-item MS Walking Scale (MSWS-12). Neurology 2003, 60:31-36. 10.1212/WNL.60.1.31, 12525714.
24. Motl R, McAuley E, Suy Y. Validity, invariance, and responsiveness of a self-report measure of functional limitations and disability in multiple sclerosis. Disabil Rehabil 2010, 32:1260-1271. 10.3109/09638280903464463, 20131947.
25. Pearson OR, Busse ME, Van Deursen RWM, Wiles CM. Quantification of walking mobility in neurological disorders. Q J Med 2004, 97:463-475.
26. Gronwall DM. Paced auditory serial addition task: A measure of recovery from concussion. Percept Mot Skills 1977, 44:367-373. 10.2466/pms.1977.44.2.367, 866038.
27. Smith A. Symbol digit modalities test: Manual 1982, Los Angeles: Western Psychological Services.
28. Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989, 39:161-166. 10.1212/WNL.39.2.161, 2915783.
29. Rousselet GA, Pernet CR. Improving standards in brain-behavior correlation analyses. Front Hum Neurosci 2012, 6:119-130. 3342588, 22563313.
30. Cohen J. Statistical power analysis for the behavioral sciences 1988, Hillsdale, NJ: Lawrence Erlbaum Associates, 2.
31. Steiger JH. Tests for comparing elements of a correlation matrix. Psych Bull 1980, 87:245-251.
32. Hobart J, Freeman J, Thompson A. Kurtzke scales revisited: The application of psychometric methods to clinical intuition. Brain 2000, 123:1027-1040. 10.1093/brain/123.5.1027, 10775547.
33. Kurtzke JF. Historical and clinical perspectives of the Expanded Disability Status Scale. Neuroepidemiology 2008, 31:1-9.
34. Lechner-Scott J, Kappo L, Hofman M, Polman CH, Ronner H, Montalban X, Tintore M, Frontoni M, Buttinelli C, Amato MP. Can the Expanded Disability Status Scale be assessed by telephone?. Mult Scler 2003, 9(2):154-159. 10.1191/1352458503ms884oa, 12708811.